查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1679398

失智症治療市場規模、佔有率、趨勢分析報告：按適應症、藥物類別、給藥途徑、分銷管道、地區、細分預測，2025-2030 年

Dementia Treatment Market Size, Share & Trends Analysis Report By Indication, By Drug Class, By Route Of Administration (Oral, Transdermal Patch, Injectable), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

失智症治療市場的成長與趨勢

根據 Grand View Research, Inc. 的一份新報告，全球失智症治療市場預計到 2030 年將達到 281.1 億美元，2025 年至 2030 年期間的複合年成長率為 8.0%。

失智症患者數量的增加、新藥的推出以及市場相關人員和研究機構日益參與開發有效的治療方法是推動市場成長的一些主要因素。根據Cross River Therapy 2023年9月發布的資料，英國阿茲海默症（AD）的盛行率約為每十萬人42.70例，是人均盛行率第二高的國家。

政府和非政府組織採取越來越多的有利舉措來支持失智症治療的宣傳宣傳活動和開發新治療方法的研究活動，預計將推動市場成長。例如，2022年2月，麥吉爾大學的失智症教育計畫獲得加拿大公共衛生署的資助，啟動了15個計劃，以提高人們對該疾病的認知。失智症社區投資 (DCI) 將提供 758,430 美元，用於支持該學院為期十週的成人學習者十個線上模組 (TOTAL)數位學習，並提高看護者的意識。

學術研究機構也從事研究活動，例如研究不同類型的失智症以及開發有效的治療方法以減輕整體疾病負擔。例如，2024年2月，科羅拉多大學安舒茲醫學院的研究人員發現，Mdm2蛋白和在臨床實驗抗癌藥物nutlin可以防止與阿茲海默症相關的突觸和樹突棘的破壞。此外，2023 年 12 月，賓州大學佩雷爾曼醫學院的臨床前研究表明，Chaperone分子與特定蛋白質結合可以逆轉大腦老化和疾病的徵兆，包括記憶力喪失。

市場先驅正在與當地參與企業和研究機構合作，以提高他們開發有效、安全的失智症治療方法的能力。 2021 年 2 月，Exscientia 與牛津大學合作開發阿茲海默症的治療方法。此外，衛材株式會社和 Biogen 已展開合作，以加速開發治療方法失智症的有效方法。兩家公司共同開發了aducanumab和lecanemab。兩家公司均已獲得全球主要監管機構對這些藥物的市場核准。

失智症治療市場報告重點

  • 由於AD失智症盛行率高，且認證核可藥數量眾多，到2024年其在適應症細分市場中佔據主導地位，佔有率達59.8%。
  • 由於發病率和嚴重程度不斷增加，路易氏體失智症(LBD) 領域預計將在 2025 年至 2030 年間以最快的複合年成長率成長。
  • 膽鹼酯酶抑制劑領域在 2024 年佔據最大佔有率，這得益於其較高的口服和經皮吸收貼片組合。
  • 由於組合藥物的有效性和採用率不斷提高，預計組合藥物領域將在 2025 年至 2030 年間以最快的複合年成長率成長。
  • 由於生技藥品的引入和有前景的注射劑的出現，預計注射劑領域將在 2025 年至 2030 年間實現最快的複合年成長率。
  • 2024 年，北美將主導全球市場，原因包括該地區疾病盛行率高、市場參與企業強大以及報銷政策更好等因素。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章失智症治療市場變數、趨勢和範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析—波特五力分析
    • PESTLE分析
    • 管道分析

第4章失智症治療市場：適應症業務分析

  • 2024年及2030年的指示市場佔有率
  • 指示細分儀表板
  • 2018 年至 2030 年市場規模、預測與趨勢分析（按適應症）
  • 阿茲海默症失智症
  • 血管性失智症
  • 路易氏體失智症
  • 額顳葉型失智症（FTD）
  • 帕金森氏症失智症
  • 其他

第5章失智症治療市場：藥物類業務分析

  • 2024 年及 2030 年藥品類別市場佔有率
  • 藥品類別細分儀表板
  • 2018 年至 2030 年藥品類別市場規模、預測與趨勢分析
  • 膽鹼酯酶抑制劑
  • NMDA受體拮抗劑
  • MAO抑制劑
  • 伴隨用藥
  • 其他

第6章失智症治療市場：給藥途徑業務分析

  • 2024 年及 2030 年給藥途徑市場佔有率
  • 給藥途徑細分儀表板
  • 2018 年至 2030 年按給藥途徑分類的市場規模、預測和趨勢分析
  • 口服
  • 經皮吸收貼片
  • 注射

第7章失智症治療市場：通路業務分析

  • 2024年及2030年分銷通路市場佔有率
  • 分銷通路細分儀表板
  • 2018 年至 2030 年分銷通路市場規模、預測與趨勢分析
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第8章失智症治療市場：區域估計和趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 2018-2030年各國情況
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030年各國情況
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 2018-2030年各國情況
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030年各國情況
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2018-2030年各國情況
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Eisai Co., Ltd.
    • Eli Lilly and Company
    • Novartis AG
    • DAIICHI SANKYO COMPANY, LIMITED
    • AbbVie Inc.
    • Lundbeck
    • Biogen
    • Cipla
    • Sun Pharmaceutical Industries Ltd.
    • Viatris Inc.
Product Code: GVR-4-68040-258-5

Dementia Treatment Market Growth & Trends:

The global dementia treatment market size is anticipated to reach USD 28.11 billion by 2030, registering a CAGR of 8.0% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing patient base of dementia, introduction of novel drugs, and increasing involvement of market players and research institutes to develop effective treatment for the disease are some of key factors driving market growth. According to the Cross River Therapy data published in September 2023, the prevalence of Alzheimer's disease (AD) in the UK is around 42.70 cases per 100,000 people, which makes it the country with the second-greatest number of cases per capita.

Increasing favorable initiatives undertaken by government and non-government bodies to support the awareness campaign and research activities to develop novel therapies for dementia treatment are anticipated to fuel market growth. For instance, in February 2022, McGill University's Dementia Education Program initiated 15 projects funded by the Public Health Agency of Canada to increase awareness about the disease. The Dementia Community Investment (DCI) is going to invest USD 758,430 to support the University's Ten Online Modules over Ten Weeks for Adult Learners (TOTAL) eLearning to spread awareness among caregivers.

Academic and research institutes are further involved in research activities to study different types of dementia and development of effective therapeutics to reduce the overall disease burden. For instance, in February 2024, researchers at the University of Colorado Anschutz Medical Campus found that Mdm2 protein with an investigational cancer drug, nutlin, can prevent the destruction of synapses and dendritic spines associated with Alzheimer's disease. Moreover, in December 2023, A preclinical study from the Perelman School of Medicine at the University of Pennsylvania showed that a chaperone molecule formulated specific proteins that can reverse disease signs including aging brain and memory impairment.

Market players are collaborating with regional players and research institutions to increase their capabilities to develop effective and safe therapy for dementia. In February 2021, Exscientia and the University of Oxford tied up to develop therapies for Alzheimer's disease. Moreover, Eisai Co., Ltd. and Biogen partnered to develop effective therapies for dementia earlier. These companies have jointly developed aducanumab and lecanemab. The companies are receiving market approvals for these drugs from key regulatory authorities across the globe.

Dementia Treatment Market Report Highlights:

  • The AD dementia segment dominated the indication segment market with a share of 59.8% in 2024 owing to a high prevalence of AD dementia and approved drugs
  • The Lewy body dementia (LBD) segment is expected to grow at the fastest CAGR from 2025 to 2030 owing to the increasing incidence and severity of the disease
  • The cholinesterase inhibitors segment held the largest share in 2024 owing to high prescription rate of oral and transdermal patches of these drugs
  • The combination drug segment is projected to experience the fastest CAGR from 2025 to 2030 owing to increased effectiveness and adoption of combination drugs
  • The injectables route of administration segment is anticipated to register the fastest CAGR from 2025 to 2030 owing to the introduction of biological drugs and the presence of promising injectable drugs in the pipeline
  • North America dominated the global market in 2024 owing to factors, such as high disease prevalence, presence of strong market players, and better reimbursement policies in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Indication
    • 1.2.2. Drug Class
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Dementia Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Dementia Treatment Market: Indication Business Analysis

  • 4.1. Indication Market Share, 2024 & 2030
  • 4.2. Indication Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Indication, 2018 to 2030 (USD Million)
  • 4.4. Alzheimer's Disease Dementia
    • 4.4.1. Alzheimer's Disease Dementia Market, 2018 - 2030 (USD Million)
  • 4.5. Vascular Dementia
    • 4.5.1. Vascular Dementia Market, 2018 - 2030 (USD Million)
  • 4.6. Lewy Body Dementia
    • 4.6.1. Lewy Body Dementia Market, 2018 - 2030 (USD Million)
  • 4.7. Frontotemporal Dementia (FTD)
    • 4.7.1. Frontotemporal Dementia (FTD) Market, 2018 - 2030 (USD Million)
  • 4.8. Parkinson Disease Dementia
    • 4.8.1. Parkinson Disease Dementia Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Dementia Treatment Market: Drug Class Business Analysis

  • 5.1. Drug Class Market Share, 2024 & 2030
  • 5.2. Drug Class Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2018 to 2030 (USD Million)
  • 5.4. Cholinesterase Inhibitors
    • 5.4.1. Cholinesterase Inhibitors Market, 2018 - 2030 (USD Million)
  • 5.5. NMDA Receptor Antagonist
    • 5.5.1. NMDA Receptor Antagonist Market, 2018 - 2030 (USD Million)
  • 5.6. MAO Inhibitors
    • 5.6.1. MAO Inhibitors Market, 2018 - 2030 (USD Million)
  • 5.7. Combination Drugs
    • 5.7.1. Combination Drugs Market, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Dementia Treatment Market: Route of Administration Business Analysis

  • 6.1. Route of Administration Market Share, 2024 & 2030
  • 6.2. Route of Administration Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2018 to 2030 (USD Million)
  • 6.4. Oral
    • 6.4.1. Oral Market, 2018 - 2030 (USD Million)
  • 6.5. Transdermal Patch
    • 6.5.1. Transdermal Patch Market, 2018 - 2030 (USD Million)
  • 6.6. Injectable
    • 6.6.1. Injectable Market, 2018 - 2030 (USD Million)

Chapter 7. Dementia Treatment Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2024 & 2030
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 7.5. Retail Pharmacies
    • 7.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 7.6. Online Pharmacies
    • 7.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 8. Dementia Treatment Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. U.S. Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Canada Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. Mexico Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. UK Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Germany Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. France Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Competitive Insights
      • 8.5.5.4. Italy Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Competitive Insights
      • 8.5.6.4. Spain Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Competitive Insights
      • 8.5.7.4. Norway Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Competitive Insights
      • 8.5.8.4. Denmark Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Competitive Insights
      • 8.5.9.4. Sweden Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Japan Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. China Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. India Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. South Korea Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Competitive Insights
      • 8.6.6.4. Australia Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Competitive Insights
      • 8.6.7.4. Thailand Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Brazil Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Argentina Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Dementia Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. South Africa Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Saudi Arabia Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. UAE Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Kuwait Dementia Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Eisai Co., Ltd.
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Eli Lilly and Company
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Novartis AG
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. DAIICHI SANKYO COMPANY, LIMITED
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. AbbVie Inc.
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Lundbeck
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Biogen
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Cipla
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Sun Pharmaceutical Industries Ltd.
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. Viatris Inc.
      • 9.5.10.1. Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global dementia treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 5. Global dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 6. Global dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 7. Global dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 8. North America dementia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 9. North America dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 10. North America dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 11. North America dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 12. North America dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13. U.S. dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 14. U.S. dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 15. U.S. dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 16. U.S. Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 17. Canada dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 18. Canada dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 19. Canada dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 20. Canada dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 21. Mexico dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 22. Mexico dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 23. Mexico dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 24. Mexico dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25. Europe dementia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 26. Europe dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 27. Europe dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 28. Europe dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 29. Europe dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30. UK dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 31. UK dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 32. UK dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 33. UK Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34. Germany dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 35. Germany dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 36. Germany dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 37. Germany dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 38. France dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 39. France dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 40. France dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 41. France Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42. Italy dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 43. Italy dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 44. Italy dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 45. Italy dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46. Spain dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 47. Spain dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 48. Spain dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 49. Spain dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50. Norway dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 51. Norway dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 52. Norway dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 53. Norway Dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54. Denmark dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 55. Denmark dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 56. Denmark dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 57. Denmark dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58. Sweden dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 59. Sweden dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 60. Sweden dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 61. Sweden dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific dementia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 67. Japan dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 68. Japan dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 69. Japan dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 70. Japan dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 71. China dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 72. China dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 73. China dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 74. China dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 75. India dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 76. India dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 77. India dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 78. India dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 79. Australia dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 80. Australia dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 81. Australia dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 82. Australia dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 83. South Korea dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 84. South Korea dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 85. South Korea dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 86. South Korea dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 87. Thailand dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 88. Thailand dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 89. Thailand dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 90. Thailand dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 91. Latin America dementia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 92. Latin America dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 93. Latin America dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 94. Latin America dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 95. Latin America dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 96. Brazil dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 97. Brazil dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 98. Brazil dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 99. Brazil dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 100. Argentina dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 101. Argentina dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 102. Argentina dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 103. Argentina dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Dementia treatment market, by country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 109. South Africa dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 110. South Africa dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 111. South Africa dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 112. South Africa dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 117. UAE dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 118. UAE dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 119. UAE dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 120. UAE dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 121. Kuwait dementia treatment market, by indication, 2018 - 2030 (USD Million)
  • Table 122. Kuwait dementia treatment market, by drug class, 2018 - 2030 (USD Million)
  • Table 123. Kuwait dementia treatment market, by route of administration, 2018 - 2030 (USD Million)
  • Table 124. Kuwait dementia treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Dementia treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Indication and drug class outlook (USD Million)
  • Fig. 10 Route of administration and distribution channel outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Dementia treatment market dynamics
  • Fig. 13 Dementia treatment market: Porter's five forces analysis
  • Fig. 14 Dementia treatment market: PESTLE analysis
  • Fig. 15 Dementia treatment market: Indication segment dashboard
  • Fig. 16 Dementia treatment market: Indication market share analysis, 2024 & 2030
  • Fig. 17 Alzheimer's disease dementia market, 2018 - 2030 (USD Million)
  • Fig. 18 Vascular dementia market, 2018 - 2030 (USD Million)
  • Fig. 19 Lewy body dementia market, 2018 - 2030 (USD Million)
  • Fig. 20 Frontotemporal dementia (FTD) market, 2018 - 2030 (USD Million)
  • Fig. 21 Parkinson disease dementia market, 2018 - 2030 (USD Million)
  • Fig. 22 Others market, 2018 - 2030 (USD Million)
  • Fig. 23 Dementia treatment market: Drug class segment dashboard
  • Fig. 24 Dementia treatment market: Drug class market share analysis, 2024 & 2030
  • Fig. 25 Cholinesterase inhibitors market, 2018 - 2030 (USD Million)
  • Fig. 26 NMDA receptor antagonist market, 2018 - 2030 (USD Million)
  • Fig. 27 MAO inhibitors market, 2018 - 2030 (USD Million)
  • Fig. 28 Combination drugs market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Dementia treatment market: Route of administration segment dashboard
  • Fig. 31 Dementia treatment market: Route of administration market share analysis, 2024 & 2030
  • Fig. 32 Oral market, 2018 - 2030 (USD Million)
  • Fig. 33 Transdermal patch market, 2018 - 2030 (USD Million)
  • Fig. 34 Injectable market, 2018 - 2030 (USD Million)
  • Fig. 35 Dementia treatment market: Distribution channel segment dashboard
  • Fig. 36 Dementia treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 37 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 38 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 39 Online pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 40 Dementia treatment market revenue, by region
  • Fig. 41 Regional marketplace: Key takeaways
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 North America dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. country dynamics
  • Fig. 45 U.S. dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 Canada country dynamics
  • Fig. 47 Canada dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Mexico country dynamics
  • Fig. 49 Mexico dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Europe dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 51 UK country dynamics
  • Fig. 52 UK dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Germany country dynamics
  • Fig. 54 Germany dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 France country dynamics
  • Fig. 56 France dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 Italy country dynamics
  • Fig. 58 Italy dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 Spain country dynamics
  • Fig. 60 Spain dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 Norway country dynamics
  • Fig. 62 Norway dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 63 Sweden country dynamics
  • Fig. 64 Sweden dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark country dynamics
  • Fig. 66 Denmark dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 67 Asia Pacific dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Japan country dynamics
  • Fig. 69 Japan dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 China country dynamics
  • Fig. 71 China dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 72 India country dynamics
  • Fig. 73 India dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 74 Australia country dynamics
  • Fig. 75 Australia dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 76 South Korea country dynamics
  • Fig. 77 South Korea dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 78 Thailand country dynamics
  • Fig. 79 Thailand dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 80 Latin America dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 81 Brazil country dynamics
  • Fig. 82 Brazil dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 83 Argentina country dynamics
  • Fig. 84 Argentina dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 85 MEA dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 86 South Africa country dynamics
  • Fig. 87 South Africa dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 88 Saudi Arabia country dynamics
  • Fig. 89 Saudi Arabia dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 90 UAE country dynamics
  • Fig. 91 UAE dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 92 Kuwait country dynamics
  • Fig. 93 Kuwait dementia treatment market, 2018 - 2030 (USD Million)
  • Fig. 94 Company categorization
  • Fig. 95 Company market position analysis
  • Fig. 96 Strategic framework